Hepatitis C virus (HCV) is a hepatotropic RNA virus that causes progressive liver damage,
which might result in liver cirrhosis and hepatocellular carcinoma. Globally, between 64 and …

There have been considerable recent advances towards a better understanding of the
complex cellular and molecular network underlying liver fibrogenesis. Recent data indicate …

Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease
worldwide. The long-term impact of HCV infection is highly variable, from minimal changes …

Context New trial data and drug regimens that have become available in the last 2 years
warrant an update to guidelines for antiretroviral therapy (ART) in human immunodeficiency …

This report updates and combines earlier versions of guidelines for the prevention and
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …

Hepatitis C virus (HCV) is a major cause of liver disease worldwide and a potential cause of
substantial morbidity and mortality in the future. The complexity and uncertainty related to …

Background Despite declines in morbidity and mortality with the use of combination
antiretroviral therapy, its effectiveness is limited by adverse events, problems with …

Background The combination of daclatasvir, a hepatitis C virus (HCV) NS5A inhibitor, and
the NS5B inhibitor sofosbuvir has shown efficacy in patients with HCV monoinfection. Data …

Background An increasing proportion of deaths among human immunodeficiency virus (HIV)–
infected persons with access to combination antiretroviral therapy (cART) are due to …

Background: The incidence and determinants of hepatic decompensation have been
incompletely examined among patients co-infected with HIV and hepatitis C virus (HCV) in …